Literature DB >> 8791411

Contractile protein mutations and heart disease.

K L Vikstrom1, L A Leinwand.   

Abstract

Mutations in several muscle structural proteins (the myosin heavy chain, alpha tropomyosin, cardiac troponin T and myosin binding protein C) result in a genetically dominant heart disease, hypertrophic cardiomyopathy. Biochemical data from studies of mutant myosin suggest a dominant-negative mechanism for inheritance of this disease. The most likely primary defect is sarcomere dysfunction, which is followed by the major clinical symptoms.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8791411     DOI: 10.1016/s0955-0674(96)80053-6

Source DB:  PubMed          Journal:  Curr Opin Cell Biol        ISSN: 0955-0674            Impact factor:   8.382


  29 in total

1.  Cardiac compartment-specific overexpression of a modified retinoic acid receptor produces dilated cardiomyopathy and congestive heart failure in transgenic mice.

Authors:  M C Colbert; D G Hall; T R Kimball; S A Witt; J N Lorenz; M L Kirby; T E Hewett; R Klevitsky; J Robbins
Journal:  J Clin Invest       Date:  1997-10-15       Impact factor: 14.808

Review 2.  Myofibrillar remodeling in cardiac hypertrophy, heart failure and cardiomyopathies.

Authors:  Jarmila Machackova; Judit Barta; Naranjan S Dhalla
Journal:  Can J Cardiol       Date:  2006-09       Impact factor: 5.223

3.  Myosin VIIA mutation screening in 189 Usher syndrome type 1 patients.

Authors:  M D Weston; P M Kelley; L D Overbeck; M Wagenaar; D J Orten; T Hasson; Z Y Chen; D Corey; M Mooseker; J Sumegi; C Cremers; C Moller; S G Jacobson; M B Gorin; W J Kimberling
Journal:  Am J Hum Genet       Date:  1996-11       Impact factor: 11.025

4.  No evidence for heterogeneity in oculopharyngeal muscular dystrophy.

Authors:  W Kress; B Halliger-Keller; T Grimm; H Porschke; A Engelhardt; H H Goebel; B Müller-Mysok
Journal:  J Med Genet       Date:  1998-07       Impact factor: 6.318

Review 5.  Unconventional myosins, the basis for deafness in mouse and man.

Authors:  T Hasson
Journal:  Am J Hum Genet       Date:  1997-10       Impact factor: 11.025

6.  The in vitro motility activity of beta-cardiac myosin depends on the nature of the beta-myosin heavy chain gene mutation in hypertrophic cardiomyopathy.

Authors:  G Cuda; L Fananapazir; N D Epstein; J R Sellers
Journal:  J Muscle Res Cell Motil       Date:  1997-06       Impact factor: 2.698

7.  A calcineurin-dependent transcriptional pathway for cardiac hypertrophy.

Authors:  J D Molkentin; J R Lu; C L Antos; B Markham; J Richardson; J Robbins; S R Grant; E N Olson
Journal:  Cell       Date:  1998-04-17       Impact factor: 41.582

8.  Functional analysis of myosin mutations that cause familial hypertrophic cardiomyopathy.

Authors:  O Roopnarine; L A Leinwand
Journal:  Biophys J       Date:  1998-12       Impact factor: 4.033

9.  Functional analyses of troponin T mutations that cause hypertrophic cardiomyopathy: insights into disease pathogenesis and troponin function.

Authors:  H L Sweeney; H S Feng; Z Yang; H Watkins
Journal:  Proc Natl Acad Sci U S A       Date:  1998-11-24       Impact factor: 11.205

Review 10.  Genes for left ventricular hypertrophy.

Authors:  Donna K Arnett; Lisa de las Fuentes; Ulrich Broeckel
Journal:  Curr Hypertens Rep       Date:  2004-02       Impact factor: 5.369

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.